Authors: Zhu Y, Lee H, White S, Weimer AK, Monte E, Horning A, Nevins SA, Esplin ED, Paul K, Krieger G, Shipony Z, Chiu R, Laquindanum R, Karathanos TV, Chua MWY, Mills M, Ladabaum U, Longacre T, Shen J, Jaimovich A, Lipson D, Kundaje A, Greenleaf WJ, Curtis C, Ford JM, Snyder MP
Journal: Nature Cancer Pubmed: 39478119 DOI: 10.1038/s43018-024-00823-z
Atlas: Stanford University
Although three-dimensional (3D) genome architecture is crucial for gene regulation, its role in disease remains elusive. We traced the evolution and malignant transformation of colorectal cancer (CRC) by generating high-resolution chromatin conformation maps of 33 colon samples spanning different stages of early neoplastic growth in persons with familial adenomatous polyposis (FAP). Our analysis revealed a substantial progressive loss of genome-wide cis-regulatory connectivity at early malignancy stages, correlating with nonlinear gene regulation effects. Genes with high promoter–enhancer (P–E) connectivity in unaffected mucosa were not linked to elevated baseline expression but tended to be upregulated in advanced stages. Inhibiting highly connected promoters preferentially represses gene expression in CRC cells compared to normal colonic epithelial cells. Our results suggest a two-phase model whereby neoplastic transformation reduces P–E connectivity from a redundant state to a rate-limiting one for transcriptional levels, highlighting the intricate interplay between 3D genome architecture and gene regulation during early CRC progression.
Files | CRDC-GC/SB-CGC (dbGaP ) | CRDC-GC/SB-CGC (Open Access ) | Synapse (Open Access ) |
---|---|---|---|
Bulk DNA Level 1 | 78 | 0 | 0 |
Bulk DNA Level 2 | 19 | 0 | 0 |
Bulk Methylation-seq Level 1 | 44 | 0 | 0 |
Bulk Methylation-seq Level 2 | 21 | 0 | 0 |
Bulk RNA-seq Level 1 | 86 | 0 | 0 |
Bulk RNA-seq Level 3 | 0 | 0 | 24 |
CODEX Level 1 | 0 | 0 | 2 |
CODEX Level 2 | 0 | 5 | 0 |
CODEX Level 3 | 0 | 0 | 102 |
HI-C-seq Level 1 | 66 | 0 | 0 |
HI-C-seq Level 2 | 34 | 0 | 0 |
HI-C-seq Level 3 | 0 | 0 | 2 |
Imaging Level 4 | 0 | 0 | 4 |
LC-MS/MS Level 1 | 0 | 0 | 163 |
LC-MS3 Level 1 | 0 | 0 | 479 |
Mass Spectrometry Level 1 | 0 | 0 | 1 |
Mass Spectrometry Level 3 | 0 | 0 | 28 |
Mass Spectrometry Level 4 | 0 | 0 | 28 |
Shotgun MS (lipidomics) Level 1 | 0 | 0 | 50 |
scATAC-seq Level 1 | 168 | 0 | 0 |
scATAC-seq Level 2 | 3 | 0 | 0 |
scATAC-seq Level 3 | 0 | 0 | 26 |
scRNA-seq Level 1 | 108 | 0 | 0 |
scRNA-seq Level 2 | 18 | 0 | 0 |
scRNA-seq Level 3 | 0 | 0 | 54 |